We are live on ! Find out more
LA

Lifeworks Advisors Portfolio holdings

AUM $779M
1-Year Est. Return 21.25%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+21.25%
3 Year Est. Return
+53.77%
5 Year Est. Return
10 Year Est. Return
AUM
$235M
AUM Growth
+$23.1M
Cap. Flow
+$10.8M
Cap. Flow %
4.59%
Top 10 Hldgs %
26.33%
Holding
164
New
21
Increased
74
Reduced
52
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 17.76%
3 Industrials 7.84%
4 Consumer Staples 6.07%
5 Consumer Discretionary 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTIP icon
1
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$7.43M 3.16%
156,641
-24,281
-13% -$1.16M
GOVT icon
2
iShares US Treasury Bond ETF
GOVT
$43.8B
$6.91M 2.94%
301,881
+146,544
+94% +$3.4M
FTEC icon
3
Fidelity MSCI Information Technology Index ETF
FTEC
$19.6B
$6.72M 2.86%
51,431
-4,424
-8% -$525K
FHLC icon
4
Fidelity MSCI Health Care Index ETF
FHLC
$3.31B
$6.69M 2.85%
105,916
+14,794
+16% +$928K
OUNZ icon
5
VanEck Merk Gold Trust
OUNZ
$2.53B
$6.47M 2.76%
348,024
-20,754
-6% -$398K
AAPL icon
6
Apple
AAPL
$4.96T
$6.25M 2.66%
32,242
+53
+0.2% +$9.23K
JNJ icon
7
Johnson & Johnson
JNJ
$645B
$5.83M 2.48%
35,251
+6,653
+23% +$1.07M
LQD icon
8
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
$5.82M 2.48%
53,864
+25,998
+93% +$2.81M
BNDX icon
9
Vanguard Total International Bond ETF
BNDX
$82.1B
$4.94M 2.1%
101,108
+48,946
+94% +$2.39M
ORCL icon
10
Oracle
ORCL
$344B
$4.76M 2.03%
39,938
+3,956
+11% +$409K
LLY icon
11
Eli Lilly
LLY
$1.07T
$4.69M 2%
10,001
+67
+0.7% +$28.1K
MBB icon
12
iShares MBS ETF
MBB
$39.1B
$4.6M 1.96%
49,341
+23,786
+93% +$2.24M
OTIS icon
13
Otis Worldwide
OTIS
$28B
$4.45M 1.9%
49,994
+2,339
+5% +$197K
MSFT icon
14
Microsoft
MSFT
$2.9T
$4.42M 1.88%
12,967
-719
-5% -$225K
MRK icon
15
Merck
MRK
$325B
$4.4M 1.87%
38,128
+4,180
+12% +$475K
CPB icon
16
Campbell Soup
CPB
$6.7B
$4.38M 1.87%
95,914
+18,916
+25% +$975K
GILD icon
17
Gilead Sciences
GILD
$163B
$4.09M 1.74%
53,101
+11,343
+27% +$905K
PFE icon
18
Pfizer
PFE
$141B
$3.65M 1.55%
99,415
+15,520
+18% +$604K
CSCO icon
19
Cisco
CSCO
$448B
$3.63M 1.55%
70,213
+9,379
+15% +$461K
ABBV icon
20
AbbVie
ABBV
$459B
$3.27M 1.39%
24,291
+3,911
+19% +$574K
AMGN icon
21
Amgen
AMGN
$204B
$3.17M 1.35%
14,283
+2,720
+24% +$631K
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.02T
$3.08M 1.31%
25,713
+6,497
+34% +$748K
REGN icon
23
Regeneron Pharmaceuticals
REGN
$70.9B
$3.07M 1.31%
4,273
+767
+22% +$591K
SPY icon
24
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.97M 1.26%
6,696
-301
-4% -$126K
BIIB icon
25
Biogen
BIIB
$29.9B
$2.82M 1.2%
9,917
+7,456
+303% +$2.22M

Similar funds

Lifeworks Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Lifeworks Advisors held 164 positions worth $235M, up 11% from $212M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lifeworks Advisors deployed $10.8M of net new capital in Q2 2023, opening 21 new positions and adding to 74 existing holdings. Its largest new stake was Analog Devices: 5,794 shares worth $1.13M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $3.46M trimmed.

  • Lifeworks Advisors's largest Q2 2023 buy was Analog Devices: 5,794 shares worth $1.13M.
  • Lifeworks Advisors added most to iShares US Treasury Bond ETF in Q2 2023, an estimated $3.4M increase.
  • Lifeworks Advisors's biggest Q2 2023 reduction was Meta Platforms (Facebook), cutting an estimated $3.46M.
  • Lifeworks Advisors fully exited Fidelity MSCI Materials Index ETF in Q2 2023, selling an estimated $845K.
  • Lifeworks Advisors's ten largest holdings make up 26% of its $235M portfolio in Q2 2023.
  • Lifeworks Advisors opened 21 new positions and closed 8 in Q2 2023.
  • Lifeworks Advisors's portfolio value rose 11% quarter-over-quarter to $235M.

Based on Lifeworks Advisors's 13F filing for Q2 2023, filed 2 Aug 2023.